Analysis

It is a key test to know the ovarian reserve and help predict the response to stimulation, and at the ERGO Clinic we can give you the result in less than 60 minutes.

A novel genetic test that reports the genetic variants that a patient has and indicates the most appropriate type of medication for ovarian stimulation, thus obtaining the best results in terms of the number of eggs in fertility treatments.

1 in 4 patients who have to resort to assisted reproduction techniques have a displaced window of implantation, which leads to implantation failure and/or repeated miscarriages. This test can be used to diagnose this displacement and subsequently perform a vitrified embryo transfer on the correct day.

It analyzes the pathogens of Endometritis, usually related to assisted reproduction patients. This pathology is not easily diagnosed; to date this new test has the same diagnostic efficacy as the sum of the 3 tests performed so far.

Altered uterine microbiota has recently been linked to implantation failure and/or repeated miscarriages. With the result of this novel test, it is possible to know the levels of lactobacillus (beneficial for a correct implantation) and to indicate to the patient a correct prophylaxis directed to the microbiota whose levels are altered.

It combines the three previous tests (ERA, ALICE and EMMA) to offer a more complete approach to pathology at a better price.

It may reveal chromosomal abnormalities and provide an explanation for the couple’s sterility or infertility. It is performed by taking a simple blood sample.

This test helps determine the risk of having a baby with a genetic disease. Indicates whether the parents carry one or more recessive genetic mutations. Carriers are healthy individuals, but when both parents share a mutation in the same gene, their offspring may be affected.

If this test is to be performed on both the female and her male partner (or the patient and her corresponding donor), this much more economical option can be chosen.

The rationale is the same as the basic carrier test but the number of diseases to be tested for increases.

It is performed when both members of the couple (or of the patient with the corresponding donor)

The easiest way to know sperm concentration, motility and ejaculate volume. In addition, pH analysis and a report of the presence of other cell types or macroscopic manifestations of possible altered parameters are performed.

It includes a basic semen analysis plus the sperm morphology study, which indicates the percentage of spermatozoa with normal forms, and delivery of results in consultation with an explanation of the results by our embryologists.

In addition to the semen analysis with morphology, a sperm capacitation study is added to know the behavior of the sample before an assisted reproduction treatment, whether it is for insemination or in vitro fertilization. The delivery of results is done in consultation with explanation of the same by our embryologists.

It is the most complete semenogram. It includes the evaluation of concentration, motility, volume and pH, as well as a study of sperm capacitation (REM), a study of sperm DNA fragmentation (associated with poor embryo quality) and a study of sperm aneuploidy (related to implantation failure or repeated miscarriages). The delivery of results is done in consultation with explanation of the same by our embryologists.

Also performed by our embryologists. It is a complementary study to the seminogram, which consists of “washing” the semen of all the fluids and substances it contains and leaving only the spermatozoa, which are placed in a medium rich in nutritive substances. The count of motile spermatozoa obtained (REM) in this test allows us to know how many of them will be useful for Assisted Reproduction techniques.

It consists of performing a semenogram on the sample, freezing it at -196ºC and performing a new count once thawed. This allows to know the survival of spermatozoa to this process that may be necessary in many assisted reproduction techniques.

Only the evaluation of normal spermatozoa forms can be performed.

Refers to breaks or lesions in the genetic material of the sperm. The greater the number of lesions, the lower the integrity of the genetic material and the lower the chances of a full-term pregnancy.

Sometimes DNA breaks are deeper and their relevance can be known by this technique.

Using a surface functionalized with hyaluronic acid, the number of sperm that bind to it (mature sperm) versus those that do not (immature sperm) is counted. It is a very interesting technique for repeated cycles or suspicion of high sperm immaturity.

This option allows the analysis of 3 of the most innovative parameters together, single-stranded DNA fragmentation, sperm maturity and sperm aneuploidy.

It allows the analysis of 5-7 chromosomes of the spermatozoa using a sample of the patient’s semen.

It may reveal chromosomal abnormalities and provide an explanation for the couple’s sterility or infertility. It is performed by taking a simple blood sample.

This test helps determine the risk of having a baby with a genetic disease. Indicates whether the parents carry one or more recessive genetic mutations. Carriers are healthy individuals, but when both parents share a mutation in the same gene, their offspring may be affected.

Further examination (semen culture or blood test) to detect infections that alter semen quality.

Identification of the Y chromosome.

Identification of Y chromosome microdeletions related to low sperm count in the ejaculate.

Genetic study of Y chromosome microdeletions, genetic study of cystic fibrosis, DNA fragmentation of spermatozoa, study of chromosomal abnormalities in spermatozoa by means of FISH, etc.

Study of carriers of the most common genetic diseases.

It allows the genetic study of the embryo before being transferred to the uterus in order to prevent some genetic diseases or alterations that may compromise the viability of the embryo.

In case of possible chromosomal alterations and/or family history of molecular genetic disease.

We carefully study the case of those patients affected by a familial genetic disease, advising them about their reproductive future, as well as the application of any of the possible genetic diagnosis techniques.

A specific gonadal marker that provides information about a woman’s ovarian reserve and helps to predict her response to hormonal ovarian stimulation treatment with delivery of the result in less than 2 hours and advice on the same.

Also called a Pap smear, it is a painless test in which a sample of cells is taken from the cervix with a small brush to detect cancerous or precancerous lesions. Even vaginal infections are detected.

Study of carriers of recessive genetic diseases to rule out the possibility of the birth of children with severe hereditary pathologies.

Detection of Down syndrome and other aneuploidies in the 24 chromosomes plus microdeletions in maternal blood.

Analysis of chromosomes 13, 18, 21, X and Y.

Down syndrome, Edwards’ syndrome, Patau’s syndrome, Monosomy X (Turner’s syndrome), and fetal sex.

Analysis of the total of 24 chromosomes, being able to detect not only the most common pathologies such as Down Syndrome, Edwards Syndrome, Patau Syndrome, Monosomy X (Turner Syndrome) but also others associated with other chromosomes, as well as fetal sex.

First trimester miscarriages are more common than is often thought. The main cause is genetic alteration in the embryo, but it is not always possible to perform a curettage to collect the abortive remains and analyze them (or the woman prefers not to undergo this procedure).

In ERGO we have the possibility of knowing the genetic status with a simple blood test to the mother. It can be done from 6 weeks of pregnancy (as long as the remains have not yet been completely expelled), and with results in 7 days.

Early detection using angiogenic markers PLGF and sFlt-1.

Blood and urine tests at every required moment of gestation, analyzing the results by our gynecology team.

Test performed (at least) between 24 and 28 weeks of pregnancy to identify the risk of gestational diabetes.

Also called “the sugar test”, it consists of ingesting a high concentration of sugar and performing analytical determinations after 1, 2 and 3 hours. If the values are altered, there are risks for the mother and the fetus, so it is important to perform it.

At ERGO we can do this, and we even have the possibility of using a room in thecenter with a television to spend the time between extractions.